Showing results (1-10 of 776) with videos related to
Sort By:
Pageof 78
Annual Review of Pathology|January 26, 2011
Pathogenesis of myelomaKenneth C Anderson, Ruben D CarrascoCancer Research|September 18, 2014
Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapyJian-Jun Zhao, Ruben D CarrascoBlood|December 10, 2013
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistanceZe Tian, Padraig D'Arcy, Xin Wang, et al.Blood|May 14, 2009
Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cellsTeru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, et al.Blood|March 10, 2009
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implicationsTeru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, et al.Seminars in Hematology|March 16, 2004
The role of immunomodulatory drugs in multiple myelomaKenneth C AndersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Oncogenomics to target myeloma in the bone marrow microenvironmentKenneth C AndersonOncology (Williston Park, N.Y.)|September 5, 2014
Multiple myeloma: a clinical overviewKenneth C AndersonJournal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
NCCN Guidelines Update for Multiple MyelomaKenneth C AndersonPageof 78